Brief: Natco Pharma Says Celgene Corp, Bristol Myers Squibb, Breckenridge Pharmaceutical Inc. And Co Named Defendants In An Antitrust Lawsuit In US
08/09/2023 05:12
Sept 8 (Reuters) - Natco Pharma Ltd NATP.NS :
* CELGENE CORP, BRISTOL MYERS SQUIBB, BRECKENRIDGE
PHARMACEUTICAL
INC. AND CO NAMED DEFENDANTS IN AN ANTITRUST LAWSUIT IN US
* LAWSUIT BY LOUISIANA HEALTH SERVICE & INDEMNITY COMPANY
D/B/A
BLUE CROSS AND BLUE SHIELD OF LOSISIANA AND HMO LOUISIANA INC
* LAWSUIT REGARDING POMALIDOMIDE
* NATCO BELIEVES THIS MATTER IS WITHOUT MERIT
Source text for Eikon: ID:nBSEbkLBNG
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees